Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Forecasted Market Size Estimates For The Cellular Therapy Tracking Market Between 2025 And 2029?
The cellular therapy tracking market has seen substantial growth recently. This market is expected to expand from $2.56 billion in 2024 to $2.90 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.3%. The market’s past growth can be ascribed to several factors, including an increase in clinical trials for regenerative medicine, a heightened emphasis on personalized medicine, the expansion of academic and industry collaborations, a rising awareness of cell therapy efficacy and safety, and growing investment and venture funding into cell and gene therapy companies.
The cellular therapy tracking market is projected for significant expansion in the coming years. It is forecast to reach $4.71 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.9%. This anticipated growth is linked to factors such as the increasing acceptance of personalized and precision medicine, an expanding portfolio of cell and gene therapies, a rise in clinical trials and subsequent commercial approvals, the growing prevalence of chronic and rare conditions, and the expansion of facilities for cell therapy manufacturing. Key trends expected during this period involve the incorporation of cell therapy tracking into digital health platforms, the integration of bioinformatics within cellular research, ongoing advancements in cellular therapy research, integrated tools for regulatory compliance, and the adoption of AI and machine learning.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28162&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Cellular Therapy Tracking Industry?
The expanding integration of personalized medicine is projected to propel the expansion of the cellular therapy tracking market in the future. Personalized medicine defines a healthcare methodology that customizes treatment and prevention plans based on a person’s distinct genetic profile, lifestyle choices, and environmental factors. This growing embrace of personalized medicine is largely attributed to developments in genomics, facilitating accurate detection of genetic differences and the creation of bespoke treatments for patients. Cellular therapy tracking complements personalized medicine by guaranteeing meticulous oversight and handling of patient-specific cells across the entire therapeutic journey. This system improves treatment safety and effectiveness through comprehensive traceability, adherence to regulations, and efficient operational processes for medical professionals. For example, data from February 2024, shared by the US-based nonprofit Personalized Medicine Coalition (PMC), indicates that the U.S. Food and Drug Administration (FDA) granted approval to 26 new personalized medicines in 2023, marking a notable rise from the 12 approvals in 2022. Consequently, the rising uptake of personalized medicine is fueling the expansion of the cellular therapy tracking market.
What Are The Major Segment Types Covered In The Cellular Therapy Tracking Market?
The cellular therapy tracking market covered in this report is segmented as
1) By Product Type: Software, Services
2) By Application: Cancer, Cardiovascular Diseases, Musculoskeletal Disorders, Autoimmune Diseases, Other Applications
3) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End Users
Subsegments:
1) By Software: Patient Registry Software, Clinical Trial Management Software, Electronic Data Capture (EDC) Systems, Laboratory Information Management Systems (LIMS), Cell Therapy Supply Chain Management Software, Compliance And Reporting Software, Data Analytics And Visualization Tools
2) By Services: Implementation And Integration Services, Training And Education Services, Consulting Services, Managed Services, Technical Support And Maintenance, Data Security And Compliance Services
Which Market Trends Are Creating New Opportunities In The Cellular Therapy Tracking Industry?
Leading companies in the cellular therapy tracking market are concentrating on developing adaptable platforms, such as chain of identity (COI) management platforms, to ensure cell traceability, regulatory adherence, and patient security. Chain of identity (COI) management platforms are digital systems that supervise and authenticate the identity of patient-specific cells throughout the complete cellular therapy process, ensuring traceability and patient safety. For instance, in May 2023, TrakCel Limited, a UK-based software company, unveiled OCELLOS Core. This new addition to its OCELLOS suite is engineered as a Chain of Identity (COI) management platform for early-stage autologous and personalized cell and gene therapy (CGT) clinical trials. It provides automated COI tracking, guaranteeing accurate patient records from the initial enrollment. The pre-configured, validated system can be deployed within 2–3 weeks, offering cost-effective scalability as therapies advance from trials to commercialization. It also monitors chain of custody events with comprehensive audit trails, thereby enhancing compliance and cooperation.
Which Major Firms Are Strengthening Their Position In The Cellular Therapy Tracking Industry?
Major companies operating in the cellular therapy tracking market are Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Gilead Sciences Inc., Merck KGaA, GE Healthcare Technologies Inc., Becton Dickinson and Company, Lonza Group Ltd., Nikon Corporation, Charles River Laboratories International Inc., Sartorius AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Vericel Corporation, Adaptimmune Therapeutics plc, Medipost Co. Ltd., and TrakCel.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/cellular-therapy-tracking-global-market-report
Which Global Regions Are Influencing The Competitive Landscape Of The Cellular Therapy Tracking Market?
North America was the largest region in the cellular therapy tracking market in 2024. The regions covered in cellular therapy tracking report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Cellular Therapy Tracking Market Report:
https://www.thebusinessresearchcompany.com/customise?id=28162&type=smp
Browse Through More Reports Similar to the Global Cellular Therapy Tracking Market 2025, By The Business Research Company
Cell Therapy Technologies Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report
Cells Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report
Therapeutic Drug Monitoring Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model